As of September 2024 Medicenna Therapeutics has 64.74M shares outstanding, a increase of 19.25% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 64.74M | 19.25% |
2022 | 54.29M | 9.31% |
2021 | 49.66M | 55.68% |
2020 | 31.90M | - |